Sign In
Buy SLS
$8.23
-0.81 (-8.96%)
At Close: Jun 05, 2026
What's Up With Sellas Life Sciences Stock Today?
01:02pm, Friday, 14'th May 2021
Sellas Life Sciences Group Inc (NASDAQ:SLS) shares are trading higher by 8.3% at $8.24 after the company reported first-quarter EPS results up from last year. Sellas Life Sciences reported quarterly
SELLAS Life Sciences Reports First Quarter 2021 Financial Results and Provides Business Update
04:25pm, Thursday, 13'th May 2021
Received $1.0 Million Milestone Payment and Recognized $5.7 Million of License Revenue Under Exclusive License Agreement with 3D Medicines for Development and Commercialization of Galinpepimut-S (GPS)
SELLAS Life Sciences to Host Shareholder Update Call on June 3rd
07:30am, Tuesday, 11'th May 2021
NEW YORK, May 11, 2021 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) ("SELLAS" or the “Company”), a late-stage clinical biopharmaceutical company focused on developing novel c
SELLAS Life Sciences Reports Full Year 2020 Financial Results and Provides Business Update
04:21pm, Tuesday, 23'rd Mar 2021
Entered into Exclusive License Agreement, with $7.5 Million Upfront License Fee and Potential to Receive up to an Additional $194.5 Million, with 3D Medicines for Development and Commercialization of
SELLAS Life Sciences to Participate in the M Vest and Maxim Group Inaugural Emerging Growth Virtual Conference on March 17th
08:30am, Thursday, 11'th Mar 2021
NEW YORK, March 11, 2021 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) ("SELLAS" or the “Company”), a late-stage clinical biopharmaceutical company focused on developing novel
Sellas: Late-Stage Biotech Approaches 2023 Approval With Solid Funding
07:29pm, Monday, 22'nd Feb 2021
SELLAS Life Sciences Group, Inc. is a late-stage biopharmaceutical company developing novel cancer immunotherapies. Sellas is currently progressing two therapeutics GalinPepimut-S (Phase 3, Fast Track
SLS Stock: 8 Things to Know About SELLAS Life Sciences as It Enjoys Reddit Bump
12:14pm, Wednesday, 03'rd Feb 2021
Shares of SLS stock are up after SELLAS Life Sciences was mentioned heavily on Reddit. Who is this company?
SLS Stock Price Increases Over 50% Pre-Market: Why It Happened
04:57am, Wednesday, 03'rd Feb 2021
The stock price of Sellas Life Sciences Group Inc (NASDAQ: SLS) is trading at over 50% pre-market today as of 4:37 AM ET. This is why it happened.
SELLAS Life Sciences Highlights 2020 Business and Clinical Progress and 2021 Milestones
08:30am, Thursday, 14'th Jan 2021
- Phase 3 REGAL Study of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) Patients Underway in United States and Europe -
Shares of Startup Biotechs Soar on Cancer Study Results
06:00pm, Monday, 28'th Dec 2020
Breast cancer is the second leading cause of death of women in the U.S. alone. Given the prevalence of the disease, it's no surprise that numerous pharmaceutical and biotech companies are searching fo
- Early Data from Study of GPS in Combination with Keytruda® in Patients with Advanced WT1(+) Ovarian Cancer Shows Disease Control Rate of 87.5% at a Median Follow-up of 9.4 Weeks and 100% Progress
SELLAS Strengthens Year-End Balance Sheet with Addition of Approximately $30.5 Million
08:30am, Thursday, 17'th Dec 2020
- Proceeds Received from Registered Direct Offering, Warrant Exercises and Upfront Fee from China Out-licensing -
SELLAS Announces Pricing of $16.2 Million Registered Direct Offering
08:10pm, Sunday, 13'th Dec 2020
NEW YORK, Dec. 13, 2020 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the developme
Why 3 Health Care Stocks Are Moving: Tv Therapeutics, Solid Biosciences, Sellas Life Sciences
12:33pm, Friday, 11'th Dec 2020
Tv Therapeutics (NASDAQ: VTVT) shares were trading higher on Friday after the company said its Phase 2 Simplici-T1 study of TTP399 achieved the primary objective of a statistically significant reduc
– Immune Stimulation Augmented by +1,300% at 6-months Post-NPS Treatment –
